Treatment with 5 μM WT161 for 72 h significantly reduced HDAC6 expression while increasing acetylated α-tubulin levels (Fig. 1c), confirming effective HDAC6 inhibition by WT161 in ALL cells. This evidence concerns the gene HDAC6 and acute lymphoblastic leukemia.